Duk-woo Park, Md
Clinical trials sponsored by Duk-woo Park, Md, explained in plain language.
-
New stomach pill tested to shield heart patients from dangerous bleeding
Disease control Recruiting nowThis study is testing if a newer stomach acid medicine (tegoprazan) works as well as a standard one (rabeprazole) to prevent serious stomach problems in heart patients. The patients are at high risk because they take long-term blood-thinning medications. Over 3,300 participants w…
Phase: PHASE4 • Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Heart showdown: surgery vs. stents for diabetics
Disease control Recruiting nowThis study aims to find out which of two common heart procedures works better for people with diabetes and severe blockages in three major heart arteries. It will compare coronary artery bypass graft (CABG) surgery with a newer, more precise type of stent procedure called state-o…
Phase: NA • Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New heart hope: can a pill stop heart failure after valve surgery?
Disease control Recruiting nowThis trial is testing if adding a once-daily pill called enavogliflozin to standard care can help prevent major heart problems in people who have had a minimally invasive heart valve replacement and also have a specific type of heart failure. The study will enroll about 1,040 par…
Phase: PHASE4 • Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Massive 10,000-Patient study tracks heart valve replacement outcomes
Knowledge-focused Recruiting nowThis study is collecting information about how patients do long-term after receiving a TAVR heart valve replacement procedure. It will follow 10,000 patients from multiple countries to see how they fare over time. The goal is to understand real-world outcomes, complications, and …
Sponsor: Duk-Woo Park, MD • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC